Norbert Straub is a pharmacist, current employed as R&D Director Pharma highly Potent at FAREVA-Excella GmbH & Co. KG in Feucht, Germany, with experience in pharmaceutical solid dose drug product development and transfer projects for more than 30 years. He closely collaborated with diverse customers on five successful FDA and EMA New Drug approvals of highly potent oral solid dosage forms in the last six years, transferring the manufacturing, packaging, and testing of more than 10 mostly highly potent OSD forms to FAREVA-Excella in the last 10 years.